(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that St. Luke’s University Health Network (SLUHN) is one of the first institutions worldwide to use Masimo SafetyNet™ to monitor in-hospital patients, as the network seeks innovative solutions to care for the surge of patients infected by COVID-19. Masimo SafetyNet is an innovative, economically scalable cloud-based patient management platform designed to ... Read more
The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological research
Portfolio includes select OTC and prescription products and two manufacturing facilities
Transaction further accelerates Company’s deleveraging plan
(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescription pharmaceutical products sold in Europe, and two ... Read more
Novel hypothesis by Edogawa Hospital researchers to hasten a relief to the pandemic
TOKYO-Saturday 25 April 2020 [ AETOS Wire ]
(BUSINESS WIRE) -- A significant discrepancy in mortality among even geographically close regions could be explained by a cross protection induced by Japanese Encephalitis Vaccine (JEV) and/or Tick-Borne Encephalitis Vaccine (TEV) according to Dr Shojiro Katoh, President, Edogawa Hospital. He along with his international team of researchers of ... Read more
فرضية جديدة من قبل باحثي مستشفى إيدوغاوا للتعجيل بتقديم الإغاقة والتصدي للوباء
طوكيو-السبت 25 أبريل 2020 [ ايتوس واير ]
(بزنيس واير): بحسب الدكتور شوجيرو كاتوه، رئيس مستشفى إيدوغاوا، يمكن تفسير وجود تباين ملحوظ في معدل الوفيات بين المناطق القريبة جغرافياً من خلال الحماية المتصالبة التي يحدثها اللقاح ضد التهاب الدماغ الياباني ("جيه إي في") و/أو اللقاح ضد فيروس التهاب الدماغ المنقول بالقراد ("تي إي في"). وقام الدكتور كاتوه، ... Read more
- تستند الموافقة إلى نتائج تجربة "إيكيلون-2" من المرحلة 3، التي برهنت أنّ العلاج باستخدام "أدسيتريس" إلى جانب "سي إتش بيه" (سيكلوفوسفاميد، ودوكسوروبيسين، وبريدنيزون) يؤدي إلى تحسين كبير على صعيد معدل البقاء على قيد الحياة بدون تطور المرض بالمقارنة مع الرعاية المعيارية -
كامبريدج، ماساتشوستس وأوساكا، اليابان -الأحد 17 مايو 2020 [ ايتوس واير ]
(بزنيس واير): أعلنت اليوم شركة "تاكيدا" للصناعات الدوائية المحدودة ("تاكيدا") ( ... Read more
– Approval is Based on Results of Phase 3 ECHELON-2 Trial, Which Demonstrated Treatment with ADCETRIS Plus CHP (cyclophosphamide, doxorubicin, prednisone) Resulted in Significant Improvement in Progression-Free Survival Compared with a Standard of Care –
(BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Commission (EC) extended the ... Read more
Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery
Roots Analysis is pleased to announce the publication of its recent study, titled, “ ... Read more
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise
Roots Analysis is pleased to announce the publication of its recent study, titled, “ ... Read more
The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations
Roots Analysis is pleased to announce the publication of its recent study, titled, “ ... Read more
The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity
INGELHEIM, Germany-Friday 29 May 2020 [ AETOS Wire ]
The opinion is for the treatment of adults with other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype beyond idiopathic pulmonary fibrosis (IPF).2
The U.S. Food and Drug Administration (FDA) and Health Canada recently approved nintedanib as the first treatment for the same patient population.3,4
Nintedanib is already approved in more than 80 countries for the treatment of ... Read more
Fact.MR recently published a market study on Hydrosurgery Systems. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities & restraints, and detailed information about the Surgical Wound Treatment market structure. The market study suggests that the global market size of Hydrosurgery Systems is projected to reach a ... Read more
- يُظهر الجمع بين "بيفونيديستات" و"أزاسيتيدين" إمكانات لمضاعفة الهدأة الكاملة وتحسين النتائج العلاجية لدى مرضى متلازمة خلل التنسج النخاعي شديدة الخطورة "إتش آر- إم دي إس"، مع ملف سلامة مماثل عند استخدام أزاسيتيدين لوحده-
- يمكن أن يكون "بيفونيديستات" أول خيار علاجي جديد لهذه المجموعة من المرضى لأكثر من عقد من الزمن –
- جلسات شفهية أثناء المُلتقى السنوي للجمعية الأمريكية لعلم الأورام السريري والمؤتمر السنوي للجمعية الأوروبية ... Read more
Fact.MR recently published a market study on Addiction Treatment. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities & restraints, and detailed information about the Addiction Treatment market structure. The market study suggests that the global market size of Addiction Treatment is projected to reach a CAGR of ... Read more
– Pevonedistat Combination Demonstrates the Potential to Double Complete Remissions and Improve Outcomes in HR-MDS, With Safety Profile Similar to Azacitidine Alone –
– Pevonedistat Could be First New Treatment Option for this Patient Population in More Than a Decade –
– Oral Presentations at the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA) Annual Meetings –
CAMBRIDGE, Mass. & OSAKA, Japan-Sunday 31 May 2020 [ AETOS ... Read more
The new market report on Asthma Spacers is a comprehensive study providing analysis on factors trend and drivers contributing to growth of the Asthma Spacers. The report is prepared with reference to historic data .Estimation of contribution of segment is expressed in terms of volume and revenue for the forecast period. Market analysis and ... Read more
Fact.MR recently published a market study on Diabetic Neuropathy. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities & restraints, and detailed information about the Diabetic Drugs market structure. The market study suggests that the global market size of Diabetic Neuropathy is projected to reach a CAGR of xx% ... Read more
Fact.MR recently published a market study on Diabetic Neuropathy. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities & restraints, and detailed information about the Diabetic Drugs market structure. The market study suggests that the global market size of Diabetic Neuropathy is projected to reach a CAGR of xx% ... Read more
Fact.MR recently published a market study on Breast Pumps. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities & restraints, and detailed information about the Breast Pumps market structure. The market study suggests that the global market size of Breast Pumps is projected to reach a CAGR of xx% over the stipulated ... Read more
Fact.MR recently published a market study on Pediatric Neuroblastoma Treatment. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities & restraints, and detailed information about the Neuroblastoma Treatment market structure. The market study suggests that the global market size of Pediatric ... Read more
The new market report on Atopic Dermatitis is a comprehensive study providing analysis on factors trend and drivers contributing to growth of the Atopic Dermatitis. The report is prepared with reference to historic data .Estimation of contribution of segment is expressed in terms of volume and revenue for the forecast period. Market ... Read more
The new market report on Rare Neurological Disease Treatment is a comprehensive study providing analysis on factors trend and drivers contributing to growth of the Rare Neurological Disease Treatment. The report is prepared with reference to historic data .Estimation of contribution of segment is expressed in terms of volume and revenue ... Read more
The new market report on Apheresis is a comprehensive study providing analysis on factors trend and drivers contributing to growth of the Apheresis. The report is prepared with reference to historic data .Estimation of contribution of segment is expressed in terms of volume and revenue for the forecast period. Market analysis and future prospect is ... Read more
- عرض شفهي للمرحلة الثانية من التحليل المؤقت لتجربة تحسين العلاج باستخدام دواء "بوناتينيب" لدى المصابين بسرطان الدم النخاعي في الاجتماع السنوي لكل من الجمعية الأمريكية لعلم الأورام السريري (إيه إس سي أو) ومؤتمر الجمعية الأوروبية لأمراض الدم (إي إتش إيه) -
- من شأن النتائج التي تدعم أنظمة الجرعات القائمة على الاستجابة لتجربة "آيكلوسيج" أن تحسن ملف الفوائد والمخاطر لدى المرضى المصابين بمرحلة مقاومة أو مزمنة من سرطان الدم النخاعي – ... Read more
